Close Brothers Group PLC
OTC:CBGPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Close Brothers Group PLC
OTC:CBGPF
|
UK |
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
Tempest Therapeutics Inc
F:3OS
|
US |
|
M
|
Medallion Financial Corp
F:MD5
|
US |
|
C
|
Corcept Therapeutics Inc
XBER:HTD
|
US |
|
E
|
Ellaktor SA
OTC:ELLKY
|
GR |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
Wall St Price Targets
CBGPF Price Targets Summary
Close Brothers Group PLC
According to Wall Street analysts, the average 1-year price target for
CBGPF is 9.65 USD with a low forecast of 7.94 USD and a high forecast of 11.59 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CBGPF's stock price target?
Price Target
9.65
USD
According to Wall Street analysts, the average 1-year price target for
CBGPF is 9.65 USD with a low forecast of 7.94 USD and a high forecast of 11.59 USD.
What is the Revenue forecast for Close Brothers Group PLC?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is -2%.